Alterity Therapeutics Limited (ATHE) DCF Valuation

Alterity Therapeutics Limited (ATHE) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Alterity Therapeutics Limited (ATHE) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or an analyst, this (ATHE) DCF Calculator is your go-to resource for accurate valuation. Equipped with real data from Alterity Therapeutics Limited, you can adjust forecasts and observe the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 2.7 3.2 2.4 2.5 2.5 2.5 2.4 2.4 2.4
Revenue Growth, % 0 0 18.06 -23.56 2.63 -0.71712 -0.71712 -0.71712 -0.71712 -0.71712
EBITDA -8.3 -12.1 -10.8 -10.9 -12.2 -1.5 -1.5 -1.5 -1.5 -1.4
EBITDA, % 100 -446.13 -339.46 -447.2 -486.94 -60 -60 -60 -60 -60
Depreciation .1 .0 .0 .1 .1 .5 .5 .5 .5 .5
Depreciation, % 100 1.74 1.06 2.61 3.67 21.82 21.82 21.82 21.82 21.82
EBIT -8.4 -12.1 -10.9 -11.0 -12.3 -1.5 -1.5 -1.5 -1.5 -1.4
EBIT, % 100 -447.87 -340.52 -449.82 -490.61 -60 -60 -60 -60 -60
Total Cash 5.7 17.5 21.7 9.8 7.9 2.5 2.5 2.4 2.4 2.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 2.6 2.9 5.4 2.5
Account Receivables, % 100 95.09 91.14 220.84 100.56
Inventories .4 .0 .0 .0 .0 .5 .5 .5 .5 .5
Inventories, % 100 0.000046087208 0 0 0 20 20 20 20 20
Accounts Payable .6 .9 1.6 1.1 .4 1.2 1.2 1.2 1.2 1.2
Accounts Payable, % 100 33.38 51.43 43.82 14.46 48.62 48.62 48.62 48.62 48.62
Capital Expenditure .0 .0 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 -0.24131 -1.74 -0.18668 -0.14236 -0.46206 -0.46206 -0.46206 -0.46206 -0.46206
Tax Rate, % -0.24158 -0.24158 -0.24158 -0.24158 -0.24158 -0.24158 -0.24158 -0.24158 -0.24158 -0.24158
EBITAT -8.1 -12.1 -10.9 -11.1 -12.3 -1.5 -1.5 -1.5 -1.4 -1.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.8 -13.9 -10.5 -14.0 -10.1 -.5 -.9 -.9 -.9 -.9
WACC, % 7.68 7.68 7.68 7.68 7.68 7.68 7.68 7.68 7.68 7.68
PV UFCF
SUM PV UFCF -3.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -16
Present Terminal Value -11
Enterprise Value -15
Net Debt -8
Equity Value -7
Diluted Shares Outstanding, MM 3,649
Equity Value Per Share 0.00

What You Will Get

  • Editable Forecast Inputs: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Alterity Therapeutics Limited’s (ATHE) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model tailored to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive Data: Alterity Therapeutics Limited's (ATHE) historical financial records and pre-populated projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Observe the recalculation of Alterity's (ATHE) intrinsic value instantly.
  • Visual Analytics: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Alterity Therapeutics Limited's (ATHE) pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for informed investment decisions.

Why Choose This Calculator for Alterity Therapeutics Limited (ATHE)?

  • Precision: Utilizes actual financial data from Alterity Therapeutics for reliable results.
  • Adaptability: Built for users to easily adjust and explore different input scenarios.
  • Efficiency: Avoid the complexities of constructing a DCF model from the ground up.
  • Expert-Level: Crafted with the expertise and attention to detail expected in high-level financial analysis.
  • Intuitive: Simple to navigate, making it accessible for users without extensive financial modeling knowledge.

Who Should Use This Product?

  • Healthcare Professionals: Understand the latest advancements in neurodegenerative disease treatments and apply them in practice.
  • Researchers: Utilize data from clinical trials to enhance studies focused on therapeutic developments.
  • Investors: Evaluate potential investment opportunities and assess the market position of Alterity Therapeutics Limited (ATHE).
  • Pharmaceutical Analysts: Optimize your analysis with a comprehensive model tailored for biotech evaluations.
  • Entrepreneurs: Learn from the strategies of established biotech firms like Alterity Therapeutics Limited (ATHE) to inform your own business plans.

What the Template Contains

  • Pre-Filled DCF Model: Alterity Therapeutics Limited’s (ATHE) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital tailored for (ATHE).
  • Financial Ratios: Assess Alterity’s (ATHE) profitability, leverage, and efficiency metrics.
  • Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to suit your analysis.
  • Financial Statements: Access annual and quarterly reports to facilitate comprehensive evaluation.
  • Interactive Dashboard: Effortlessly visualize key valuation metrics and outcomes for (ATHE).

No products were found matching.